Microbiome Report for Week Ending 2/23/19

Microbiome Report for Week Ending 2/23/19

Source: 
CP WIre
snippet: 

BiomX Raises $32 Million in Series B Financing
BiomX Ltd., a microbiome company developing customized phage therapies, announced on 2/20/19 the closing of a $32 million series B equity financing.